EDMONTON (CP) - Lower research expenses helped cancer vaccine developer Biomira Inc. narrow its first-quarter loss by $500,000 from a year ago, officials reported Thursday.
The company's net loss for the three months ended March 31, was $4....More
Friday, April 29, 2005
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment